Idiopathic inflammatory myopathies: current trends in pathogenesis, clinical features, and up-to-date treatment recommendations
- PMID: 23274022
- DOI: 10.1016/j.mayocp.2012.10.017
Idiopathic inflammatory myopathies: current trends in pathogenesis, clinical features, and up-to-date treatment recommendations
Abstract
Recently, there have been important advances in the understanding of the pathophysiologic features, assessment, and management of patients with a newly diagnosed idiopathic inflammatory myopathy (IIM). Myositis-specific autoantibodies have been identified to define patient subgroups and offer prognostic implications. Similarly, proinflammatory cytokines, such as interleukin 6 and type 1 interferon-dependent genes, may serve as potential biomarkers of disease activity in adult and juvenile patients with dermatomyositis (DM). Moreover, magnetic resonance imaging has become an important modality for the assessment of muscle inflammation in adult IIM and juvenile DM. Immune-mediated necrotizing myopathies also are being recognized as a subset of IIM triggered by medications such as statins. However, confusion exists regarding effective management strategies for patients with IIM because of the lack of large-scale, randomized, controlled studies. This review focuses primarily on our current management and treatment algorithms for IIM including the care of pediatric patients with juvenile DM. For this review, we conducted a search of PubMed and MEDLINE for articles published from January 1, 1970, to December 1, 2011, using the following search terms: idiopathic inflammatory myopathies, dermatomyositis, polymyositis, juvenile dermatomyositis, sporadic inclusion body myositis, inclusion body myositis, inflammatory myositis, myositis, myopathies, pathogenesis, therapy, and treatment. Studies published in English were selected for inclusion in our review as well as additional articles identified from bibliographies.
Copyright © 2013 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Classification, diagnosis, and management of idiopathic inflammatory myopathies.J Rheumatol. 2013 May;40(5):550-64. doi: 10.3899/jrheum.120682. Epub 2013 Mar 15. J Rheumatol. 2013. PMID: 23504386 Review.
-
Idiopathic inflammatory myopathies.Handb Clin Neurol. 2014;119:495-512. doi: 10.1016/B978-0-7020-4086-3.00032-1. Handb Clin Neurol. 2014. PMID: 24365315 Review.
-
[Idiopathic inflammatory myopathies].Pol Merkur Lekarski. 2005 May;18(107):590-4. Pol Merkur Lekarski. 2005. PMID: 16161963 Review. Polish.
-
Discovery of new biomarkers of idiopathic inflammatory myopathy.Clin Chim Acta. 2015 Apr 15;444:117-25. doi: 10.1016/j.cca.2015.02.007. Epub 2015 Feb 11. Clin Chim Acta. 2015. PMID: 25681646 Review.
-
Idiopathic inflammatory myopathies.J Neuroimmunol. 2011 Feb;231(1-2):32-42. doi: 10.1016/j.jneuroim.2010.10.013. Epub 2010 Nov 18. J Neuroimmunol. 2011. PMID: 21093064 Review.
Cited by
-
A Case of Refractory Polymyositis Successfully Treated With Abatacept Monotherapy.Arch Rheumatol. 2020 Feb 7;35(4):618-622. doi: 10.46497/ArchRheumatol.2020.7406. eCollection 2020 Dec. Arch Rheumatol. 2020. PMID: 33758820 Free PMC article.
-
Physical therapy in adult inflammatory myopathy patients: a systematic review.Clin Rheumatol. 2019 Aug;38(8):2039-2051. doi: 10.1007/s10067-019-04571-9. Epub 2019 May 21. Clin Rheumatol. 2019. PMID: 31115788
-
Polymyositis and dermatomyositis: ocular manifestations and potential sight-threatening complications.Rheumatol Int. 2022 Jul;42(7):1119-1131. doi: 10.1007/s00296-021-05035-7. Epub 2021 Oct 21. Rheumatol Int. 2022. PMID: 34674015 Review.
-
Amyopathic Dermatomyositis Associated with Histopathological Findings of Organizing Pneumonia and Pulmonary Vasculitis.Balkan Med J. 2017 Aug 4;34(4):374-377. doi: 10.4274/balkanmedj.2016.1061. Epub 2017 Apr 13. Balkan Med J. 2017. PMID: 28443580 Free PMC article.
-
Juvenile dermatomyositis: a tertiary center experience.Clin Rheumatol. 2017 Feb;36(2):361-366. doi: 10.1007/s10067-016-3530-4. Epub 2017 Jan 5. Clin Rheumatol. 2017. PMID: 28058540
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical